| Dr Ted Steven Peterson, DPM | |
|
9 E Garfield Rd, Aurora, OH 44202-6713 | |
| (330) 562-2211 | |
| Not Available |
| Full Name | Dr Ted Steven Peterson |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 48 Years |
| Location | 9 E Garfield Rd, Aurora, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598780553 | NPI | - | NPPES |
| 0321904 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | 36.001787 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ted Steven Peterson, DPM 10440 Wye Road, Chesterland, OH 44026-3326 Ph: (440) 285-9086 | Dr Ted Steven Peterson, DPM 9 E Garfield Rd, Aurora, OH 44202-6713 Ph: (330) 562-2211 |
News Archive
As we seek a better understanding of the workings of the human mind, we are continually confronted by fresh ethical, legal, and social questions. Now, researchers are increasingly emphasizing the role of a new discipline, neuroethics, to guide the search for answers to those questions.
Major progress has been made in the past 30 years in the knowledge and management of liver disease, yet approximately 29 million Europeans still suffer from a chronic liver condition. The European Association for the Study of the Liver (EASL) today unveiled its new publication The burden of liver disease in Europe: a review of available epidemiological data.
A USC-led team of scientists has found that a fasting-mimicking diet combined with hormone therapy has the potential to help treat breast cancer, according to newly published animal studies and small clinical trials in humans.
Publicis Groupe announced today that it has acquired U-Link Business Solutions Co. Ltd (UBS), one of the leading Chinese agencies specialized in healthcare communications.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, and Shire plc, the global specialty biopharmaceutical company, today announced a joint development and commercialization agreement for ACE-031 and other novel molecules targeting the activin receptor type IIB (ActRIIB) pathway. This pathway plays critical roles in regulating the growth of skeletal muscle.
› Verified 4 days ago
Dr. Charlene Roberta Krejci-simmons, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 945 Lake Ave, Aurora, OH 44202 Phone: 330-995-0218 Fax: 330-995-0218 |